Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter” or the "Company”), a clinical-stage pharmaceutical company developing JOTROL ™, a patented resveratrol-based platform, today issued a statement ...

The "plus” in Trialtrove+ and Sitetrove+ represents a broad set of new features designed to create additional efficiencies for clinical researchers, sponsors and planners, including: Proprietary ...